Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 15, 2025 08:00 ET | Source: ZenaTech Inc.

ZenaTech to Accelerate ZenaDrone Manufacturing for US Defense and Commercial Drones Following Recent One Big Beautiful Bill, Executive Orders, and Secretary of Defense Policy Directives

VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI...
July 15, 2025 07:30 ET | Source: BriaCell Therapeutics Corp.

BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer

PHILADELPHIA and VANCOUVER, British Columbia, July 15, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...
July 14, 2025 08:00 ET | Source: Ultragenyx Pharmaceutical Inc.

Health Canada Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)

TORONTO, July 14, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialisation of novel therapies for rare and...
July 11, 2025 10:03 ET | Source: ZenaTech Inc.

ZenaTech Reacts to ‘Unleashing U.S. Military Drone Dominance’ Memo — A Game-Changing Policy Directive for ZenaDrone

VANCOUVER, British Columbia, July 11, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI...
July 09, 2025 07:30 ET | Source: BriaCell Therapeutics Corp.

BriaCell Patient Achieves Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Metastatic Breast Cancer Study

[IMAGES BELOW] Complete resolution maintained at 6 months in first patient treated with BriaCell’s Bria-OTS in Phase 1/2a studyNo treatment limited toxicities observedPatient remains on study with...
July 08, 2025 08:00 ET | Source: ZenaTech Inc.

ZenaTech Poised to Benefit from Historic US Defense Spending─$33 Billion for Drone and Autonomy Investments in ‘One Big Beautiful Bill’

VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence)...
July 08, 2025 07:00 ET | Source: Microbix Biosystems Inc.

Microbix & Bulgaria’s NCIPD Execute Supply Agreement

MISSISSAUGA, Ontario and SOFIA, Bulgaria, July 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and...
July 08, 2025 04:05 ET | Source: Research and Markets

Canada Diabetes Devices and Therapeutics Market Report 2025 | Provincial Reimbursements and Regulatory Shifts Propel CGM Usage, Smart Insulin Technology and Digital Health Platforms Drive Growth

Dublin, July 08, 2025 (GLOBE NEWSWIRE) -- The "Canada Diabetes Devices and Therapeutics Market Investment Opportunities - Q2 2025 Update" report has been added to ResearchAndMarkets.com's...
July 02, 2025 07:30 ET | Source: BriaCell Therapeutics Corp.

BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven

Together, Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven add 30 satellite locations to enroll patients in BriaCell’s pivotal Phase 3 studyBriaCell’s Phase 3 study currently...
June 26, 2025 15:27 ET | Source: America’s Blood Centers

America's Blood Centers Honors HOSA-Future Health Professionals Lifesaving Impact at 2025 International Leadership Conference

Washington, DC, June 26, 2025 (GLOBE NEWSWIRE) -- America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation’s blood...